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ABSTRACT Although much is known about fibrin polymerization, because it is complex, the effects of various modifications are not
intuitively obvious and many experimental observations remain unexplained. A kinetic model presented here that is based on information
about mechanisms of assembly accounts for most experimental observations and allows hypotheses about the effects of various
factors to be tested. Differential equations describing the kinetics of polymerization were written and then solved numerically. The results
have been related to turbidity profiles and electron microscope observations. The concentrations of intermediates in fibrin polymeriza-
tion, and fiber diameters, fiber and protofibril lengths have been calculated from these models. The simplest model considered has three
steps: fibrinopeptide A cleavage, protofibril formation, and lateral aggregation of protofibrils to form fibers. The average number of
protofibrils per fiber, which is directly related to turbidity, can be calculated and plotted as a function of time. The lag period observed in
turbidity profiles cannot be accurately simulated by such a model, but can be simulated by modifying the model such that oligomers
must reach a minimum length before they aggregate. Many observations, reported here and elsewhere, can be accounted for by this
model; the basic model may be modified to account for other experimental observations. Modeling predicts effects of changes in the
rate of fibrinopeptide cleavage consistent with electron microscope and turbidity observations. Changes only in the rate constants for
initiation of fiber growth or for addition of protofibrils to fibers are sufficient to account for a wide variety of other observations, e.g., the
effects of ionic strength or fibrinopeptide B removal or thrombospondin. The effects of lateral aggregation of fibers has also been
modeled: such behavior has been observed in turbidity curves and electron micrographs of clots formed in the presence of platelet
factor 4. Thus, many aspects of clot structure and factors that influence structure are directly related to the rates of these steps of
polymerization, even though these effects are often not obvious. Thus, to a large extent, clot structure is kinetically determined.
INTRODUCTION
Fibrinogen is the key structural protein in blood clotting.
It is a fibrous protein with a molecular mass of 340 kD
made up of three pairs of polypeptide chains held to-
gether by disulfide bonds. Fibrinogen is converted to fi-
brin by enzymatic cleavage of the fibrinopeptides by
thrombin; the pair ofA fibrinopeptides is removed first,
usually followed by the pair of B fibrinopeptides as the
clot is formed. Fibrin monomers aggregate in a half stag-
gered manner via complementary binding sites to form
small oligomers which grow into longer structures, called
two-stranded protofibrils. Protofibrils then aggregate lat-
erally to produce fibers, which are paracrystalline struc-
tures with a distinctive band pattern. Fibers aggregate
with each other to a variable extent depending on the
ionic conditions to form fiber bundles, which branch,
yielding a three-dimensional network or gel.
Many of these structures have been observed by elec-
tron microscopy, revealing details of the structures and
the assembly process. Clot formation is commonly mon-
itored by the measurement of turbidity as a function of
time. The coordinated use ofboth light scattering or tur-
bidity, which measures average parameters well, with
electron microscopy, which is better for direct visualiza-
tion of the detailed structures, is powerful. The kinetics
of early events in clot formation, such as the cleavage of
the A and B fibrinopeptides and the formation of small
oligomers, have been investigated (e.g., Janmey, et al.,
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1983; Lewis, et al., 1985; Wilf and Minton, 1986; Sato
and Nakajima, 1984; Wolfe and Waugh, 1981). The
shape ofthe typical turbidity curves observed in clot for-
mation has been analyzed (Hantgan and Hermans,
1979). There is a lag period which corresponds to the
time required for the formation and growth of protofi-
brils from fibrin monomer after the removal of fibrino-
peptides. The rapid rise in turbidity results from lateral
aggregation of protofibrils that have reached a certain
minimum length. The final value of turbidity when it
levels off is related directly to the average size of the
fibers or fiber bundles. It has been demonstrated that clot
turbidity is directly proportional to the average cross-sec-
tional area of the fibers comprising it (Carr and Her-
mans, 1978).
Much experimental work has been performed on the
effects of various modifications of clotting conditions on
the shape of the turbidity curves; a few examples will be
noted here. Ferry and Morrison (1947) first investigated
the effects of modification of ionic conditions on the
turbidity curves, and many other studies followed. The
influence of many components that are normally pres-
ent in blood has also been investigated. Some examples
include: calcium (Hardy, et al., 1983; Carr, et al., 1986),
dextran (Dhall, et al., 1976; Carr and Gabriel, 1980),
immunoglobulin (Gabriel, et al., 1983), albumin (Wilf,
et al., 1985; Galanakis, et al., 1987), hydroxyethyl starch
(Carr, 1986), platelet factor 4 (Carr, et al., 1987),
thrombospondin (Bale and Mosher, 1986), collagen
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FIGURE I Modeling of the kinetics of fibrin polymerization. (a) Three-step mechanism: fibrinopeptide A cleavage; initiation and growth of
protofibrils; initiation and growth offibers. Here, the rate ofgrowth offibers is the same as the rate ofinitiation (kf. = 4i): kA = 1 s- (N.B. measured
values are larger, but there is no change in the curves for any value larger than this); kpi = Apg = 4 x 10-18 L/ molecule s (N.B., this is the rate constant
measured by Hantgan and Hermans, 1979); ki= = 10-18 L/ molecule s. (Note that the units ofthe rate constants for the calculations must be in
number units rather than moles, but they can be converted to those normally used in biochemical kinetics simply by multiplying by Avogadro's
number.) The average number of protofibrils per fiber (pf/fiber) rises rapidly and then levels off to a low number. (b) The results of the same
three-step mechanism are shown here, but now fiber growth is more rapid than initiation (kfg > kfi): kfi = 10-21 L/ molecule s; kfg = 2 x 10-17
L/molecule s (all other rate constants are the same). The average number of pf/fiber rises rapidly and levels off at a much higher value. (c) The
curve resulting from a model in which small oligomers cannot aggregate, but protofibrils must reach a certain length before they can aggregate to
form fibers; in this case protofibrils can start aggregating when they contain at least 11 monomers. The length of the lag period is dependent on the
minimum size oligomer that can aggregate. The rate constants, which also apply to all subsequent figures unless specified otherwise, are: kA = 1 s-1
(N.B., again, there is no change in the curves for any value larger than this); kmj = 4 x I0-`8 L/ molecule s (in this case, all oligomers were assumed to
associate at this same rate with other oligomers ofthe same size and with protofibrils); kAp = 101-6 L/molecules s; kfi = 10-2 L/molecule s; kf, = 2 x10-17 L/ molecule s. (d) The concentration offibrinogen molecules as a function oftime. The initial fibrinogen concentration is 5 x 1018 mol/L (or
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(Jones and Gabriel, 1988), and poly (L-amino acids)
(Carr, et al., 1989). These results are significant for sev-
eral reasons. Studies of modifications to the physical or
chemical properties of clots or the assembly process may
help to elucidate the mechanisms of assembly. Also, it
has been shown that clots produced in plasma are differ-
ent than those formed with purified fibrinogen and
thrombin (Shah, et al., 1987; Camf, 1988; Nair and
Dhall, 1991), but exactly which plasma components are
responsible for these differences is not entirely known.
Finally, it is known that clots formed in vivo can be
different in certain conditions; some of the proteins just
mentioned may be present in different amounts under
certain circumstances and may thus be responsible for
modulating clot structure.
Furthermore, modifications to fibrinogen itself also
affect the assembly process. Studies ofthe assembly prop-
erties of these modified preparations may yield insight
into the function of different portions of the molecule.
Examples include desialated or deglycosylated fibrino-
gen (Martinez, et al., 1977; Dang, et al., 1989; Langer, et
al., 1988) and many proteolytic derivatives. Some ofthe
results from such variations as those mentioned above
are easily interpreted, but others are much more compli-
cated and difficult to understand. In this paper, we de-
velop a framework to help interpret the results of such
experiments and provide examples and experimental evi-
dence in the form of electron microscopy and turbidity
curves for the effects of various modifications to the fi-
brin clotting system.
MATERIALS AND METHODS
Highly purified, plasminogen-free human fibrinogen (97-98% clott-
able) was obtained from Imco Co. (Stockholm, Sweden). Unless oth-
erwise stated, all experiments were carried out in 0.15 M NaCl, 0.05 M
Tris-HCl, pH 7.4, 1 mM CaCl2 at 22°C, using fibrinogen concentra-
tions 0.5-1.5 mg/mL. Clotting was initiated by the addition ofthrom-
bin, often to a final concentration of about 1 NIH unit/mL, but in
some experiments the thrombin concentration was varied, as described
in the text or figure legends. Turbidity was measured on a Lambda 4B
spectrophotometer (Perkin-Elmer Corp., Norwalk, CT) at 350 nm and
22°C. After equilibration of fibrinogen in the appropriate buffer, and
sometimes with another protein (as noted in the text), the absorbance
at 350 nm was adjusted to 0 and freshly prepared thrombin was added
at time 0. The optical density was sampled every 0.1 min and measured
until there was little or no further change, usually within 120 min. Each
experiment was repeated several times and data points were averaged.
Platelet factor 4 (Holt and Niewiarowski, 1989) was a generous gift
of Drs. J. Holt and S. Niewiarowski (Thrombosis Research Center,
Temple University School of Medicine, Philadelphia, PA). Thrombo-
spondin (Tuszynski, et al., 1987) was a generous gift of Dr. G. Tus-
zynski (Department of Medicine, Medical College of Pennsylvania,
Philadelphia, PA).
Fibrin monomer was prepared by the treatment of fibrinogen with
thrombin and subsequent dissolution of the resulting clot at 4°C in
acetic acid solution at pH 3.5 (Medved', et al., 1990). Protofibrils were
formed by 10-fold dilution ofconcentrated (0.4 mg/mL) acidic mono-
mer in 0.02 M phosphate buffer, pH 7.4,0.2 M NaCI, 0.1 mM CaCl2 at
37°C. With these conditions, polymerization was relatively slow,
which allowed the preparation of samples for electron microscopy at
various times during the fibrin clot formation process (Medved', et al.,
1990). Because large numbers of protofibrils are present during the lag
period ofthe turbidity curves, samples were taken for microscopy dur-
ing this time.
Samples were prepared for transmission electron microscopy by the
methods of either negative contrast or rotary shadowing. Negatively
contrasted specimens of individual molecules, protofibrils or fibers
were prepared by placing a drop on a glow-discharged carbon film and
adding 1% uranyl acetate (Weisel, 1986a; Medved', et al., 1990). Pre-
formed clots were applied to 300 mesh, glow-discharged carbon-coated
Formvar grids and then negatively contrasted with uranyl acetate. Ro-
tary-shadowed samples were prepared by spraying a dilute solution of
molecules in a volatile buffer (usually 0.05 M ammonium formate)
and glycerol (30-50%) onto freshly-cleaved mica and shadowing with
platinum in a vacuum evaporator (Denton Vacuum Co., Cherry Hill,
NJ) (Weisel, et al., 1985). All of these specimens were examined in a
Philips 400 electron microscope (Philips Electronic Instruments Co.,
Mahwah, NJ), usually operating at 80 kV and a magnification of
60,OOOx.
Scanning electron microscope experiments were carried out on clots
that were fixed, dehydrated, critical point dried and sputter-coated with
gold-palladium as described previously (Langer, et al., 1988). As much
as possible, these clots were prepared for electron microscopy in the
same way as the turbidity measurements were made; protein concen-
trations and buffer conditions were identical or similar. Samples for
scanning electron microscopy were clotted for about 20X the gelation
time in plexiglass microdialysis cells perforated for solvent perfusion.
Specimens were washed 3x with pH 7.0 phosphate buffer to remove
excess salt, fixed for 30 min in 2% glutaraldehyde, and rinsed 3x. Then,
clots were poststained for 15 min with 1% osmium tetroxide, rinsed,
and dehydrated in a series of ethanol concentrations up to 100%. The
clots were critical point dried with CO2 for -45 min in a Denton
apparatus (Denton Vacuum Co.), mounted and sputter coated with
gold palladium. Specimens were examined in an Amray 1400 scanning
electron microscope (Amray, Inc., Bedford, MA).
RESULTS
Model describing the kinetics
of fibrin formation
Experimentally, clots have been characterized by the
time course of turbidity development and electron mi-
crographs of intermediates or final fiber structure. It has
8.2 x 10-6M or 2.7 mg/mL), and there is an exponential decay as fibrinogen is converted to fibrin monomer. The rate ofdecay is dependent on the
rate of cleavage of the A fibrinopeptides or the thrombin concentration. (e) The time dependence of the fibrin monomer concentration. The fibrin
monomer concentration rises rapidly and then falls. The initial rise can be seen more easily in the expanded time scale of Fig. 2. (f) The average
concentration of protofibrils that have not yet been incorporated into fibers as a function oftime. There is a rapid rise followed by a slower decline.
(g) Protofibrils incorporated into fibers as a function oftime. There is a lag period, followed by a rapid rise in concentration which then approaches a
maximum. (h) The average number of fibers as a function of time. There is a short lag period, a very rapid increase, quickly reaching a plateau. (i)
The time course ofthe average fiber length. The maximum average length is quickly attained; the average length then remains constant or decreases
slightly. An overshoot in length sometimes occurs under kinetic conditions where fibers of shorter length are formed at later times as fibrin
monomer is depleted.
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PROTOFIBRIL
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FIGURE 2 Electron microscopy correlated with kinetic modeling ofsome steps in fibrin polymerization. The kinetic modeling curves are the same
as in Fig. 1, but the time scale is shorter to illustrate better the early events, and the values of various parameters have been normalized so that the
time courses can be compared. The curves are identified by arrows from the electron micrographs associated with them. Fibrinogen and fibrin
monomer molecules were both rotary shadowed with platinum; fibrin monomer was prepared in dilute acetic acid as described in the text. Samples
of protofibrils formed during the lag period were prepared from fibrin monomer and negatively contrasted with uranyl acetate. Fibrin fibers
produced just after the rapid rise in turbidity were also negatively stained. Images ofindividual molecules, protofibrils and the fiber are all shown at
the same magnification; the bar represents 0.1 m. The image of a clot is a scanning electron micrograph ofa critical point dried specimen formed
under roughly physiological conditions (0.15 M NaCl, 0.05 M Tris-HCl, pH 7.5). This clot image is a factor of 10 lower in magnification; the bar
here represents 1.0 um. The curve corresponding to the clot image is the average number of pf/fiber, which is directly related to turbidity as one
measure of clot formation.
been demonstrated that the turbidity of clots is directly
related to clot structure. Under most conditions, clot tur-
bidity is proportional to the square ofthe average radius
ofthe fibers (Carr and Hermans, 1978). Thus, turbidity
is also proportional to the average number ofprotofibrils
per fiber, assuming that fiber density is constant. Obvi-
ously, fiber diameters can be measured directly from
electron micrographs. The average number of protofi-
brils per fiber has been calculated from kinetic models
for direct comparison with experimental electron micro-
scope and turbidity data.
The formation of a fibrin clot is commonly described
as consisting ofat least three steps: (a) the cleavage ofthe
A fibrinopeptides by the enzyme thrombin; (b) associa-
tion of fibrin monomers to form two-stranded protofi-
brils; and (c) aggregation ofprotofibrils to produce fibers
which branch to yield a gel. Other steps and complica-
tions that arise from this simplified scheme will be dis-
cussed below. Aspects of the kinetics of the enzymatic
reaction and subsequent molecular association have
been studied (e.g., Janmey, et al., 1983; Lewis, et al.,
1985; Wilf and Minton, 1986; Sato and Nakajima,
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1984). Here, the kinetics of development of turbidity
has been modeled, so these initial steps are oversimpli-
fied. We intentionally begin with a very simple model so
that its limitations can be explored. The chemical reac-
tions and their associated rate constants may be written
as follows, where fA represents fibrinogen, f is fibrin
monomer, fn is protofibrils andfr represents fibers:
f kA f
f + f
-fn
fibrinopeptide A cleavage to convert fibrinogen
to fibrin
fibrin monomers associate, initiating protofibril
formation
f, + f f,, protofibrils grow in length
f, + fn fr two protofibrils aggregate to initiate a fiber
kf5
fr + fn -) fr additional protofibrils add to a growing fiber.
Both aggregation steps, offibrin monomers and ofproto-
fibrils, have been subdivided into initiation and growth
reactions so that the sizes of the resulting structures can
be modeled.
The differential equations describing the kinetics of
these reactions are:
d[fAI = k[f]
_tkA fA]-kif][f]-p f][n]
dt
dtf = k_[fA] 2kf[f ][fn kpg[f][fn]dt
d[fn] = ki[f][f
dt
k I[ 2kfi[fn ][fn, k%[fr] [fn]
dt
In addition, if [f Int] = total protofibrils in fibers, then
dt 2kfi[fn ] [fn ] + kfg[fr] [fn]
and the average number of protofibril/fiber, m =
Ifn ]/[ft].
Using these relationships, and number average con-
centrations and rate constants based on those in the liter-
ature (e.g., Hantgan and Hermans, 1979; Lewis, et al.,
1985; Wilfand Minton, 1986; Smith, 1984; note that all
ofthe particular rate constants used for each experiment
shown are given in the figure legends), the differential
equations were solved numerically using an explicit
Runge-Kutta method. The average number of protofi-
brils per fiber was calculated as a function oftime (Fig. 1
a). Several features of typical experimental turbidity
curves are observed. The average fiber size increases rap-
idly and then reaches a plateau. However, the average
maximum number of protofibrils per fiber is very low.
To simulate the real fiber diameters observed by electron
microscopy or calculated from turbidity data, it was
found to be necessary that addition of protofibrils to ex-
isting fibers be kinetically favored over initiation of new
fibers by two protofibrils coming together. In other
words, kfg must be larger than kfi. Under these condi-
tions, a typical profile of turbidity is shown in Fig. 1 b.
Note that there are no published values for kfi and kfg,
but that the rates for association of protofibrils can be
relatively fast even though the structures involved are
large because an increase in target area would compen-
sate for the decrease in diffusion rate for such large struc-
tures. In summary, with these rate constants, the ob-
served average number of protofibrils per fiber is consis-
tent with values determined experimentally from
electron microscopy or turbidity data.
Alternatively, it may be that larger fibers are formed
by the aggregation of smaller fibers, rather than simply
adding protofibrils. This possibility was also modeled,
simply by subtracting a term, kfa[fr] [ft], where kfa is the
rate of fiber-fiber association, from the equation for the
rate of change of the fiber concentration and adding the
same term to the equation for the rate of change of total
protofibrils in fibers. The average number of protofibrils
per fiber can be increased in this way, but the curves are
very different in shape than those in Fig. 1 b, where the
values for fiber size reach a plateau, (i.e., the slope ofthe
curves approaches zero). Instead, when fiber aggrega-
tion is sufficient to yield fibers with normal diameters
and kfg = kfi, the slope ofthe curve for fiber size increases
with time. Thus, fiber aggregation alone cannot account
for both the shape ofthe curves and the magnitude ofthe
final average fiber sizes reflected in the observed turbid-
ity curves and electron micrographs.
The most serious problem with this model, however, is
the failure to simulate the observed lag period. As might
be expected, two of the rate constants particularly affect
the initial portions of the curve, the rate of fibrinopep-
tide cleavage (kA) and the rate of initial fibrin monomer
association (kpi). Decreasing either of these rate con-
stants leads to a decrease in the maximal rate of fiber
growth. Further decreases lead to the introduction of a
lag period, but not before the shape of the curves has
been seriously affected. At the point that a perceptible
lag period appears, the slopes of the curves are greatly
decreased and they rise slowly without reaching a
plateau. In summary, it is not possible to simulate all
observed features ofthe turbidity curves with such a sim-
ple model.'
' The relationship between turbidity and fiber size was developed for
long fibers, i.e., those approaching the wavelength oflight in length. To
ensure that the lack of a lag period with this first model did not result
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As shown by Hantgan and Hermans (1979), the lag
period appears to be a result of the time necessary for
protofibrils to grow to sufficient length before they aggre-
gate. Such a requirement can be built into the model by
defining the initial steps of protofibril formation explic-
itly and requiring that protofibrils reach a minimum
length before they aggregate. The minimum length de-
fined here is arbitrary; the minimum length actually em-
ployed in modeling can be based on experimental evi-
dence, as described below.
fAf
fibrinopeptide A cleavage to convert fibrinogen
to fibrin
fibrin monomers associate to yield small oligo-
mers, initiating protofibril formation
f2 + ff3
fo + f fn longer oligomers are formed, protofibrils capable
of association
fn + fP- fn protofibrils grow in length
f, + fn -*fr two protofibrils aggregate to initiate a fiber
ft + fn -fi ft additional protofibrils add to a growing fiber.
The equations describing the kinetics of these reactions
are:
d[fA]
-kA[fA]
dt
dtfI kA[fA]- kpi[f](2 [f] + [f2] +[f- ]
+ ***+ [flo))- kpg[f] [fn I
from the oversimplification of ignoring the effects of shorter fibers at
early times, we can assume that short fibers do not contribute to turbid-
ity. (This assumption is probably not valid but is one most likely to
produce a lag period.) Then, ifwe plot the average number of protofi-
brils per fibers that are at least 15 monomers long (which is -350 nm,
the wavelength of light used to measure turbidity), there is still no lag
period. This result may be understood qualitatively by examination of
Fig. 1i, which shows that fiber size rises very rapidly. Note that this
oversimplification does not even need to be considered for all of the
subsequent modeling because of the condition that oligomers reach a
certain minimum length before they can aggregate to form fibers.
d[f2]
dt kpi[f]([f] - If2])
d[fi3 ]-= kpi[fI(f2] - [A] )
dt
d[fo]= kpi[f I Qfg I - [fo ])dt = kpi[f](If9]- [ [ol)
d[f]=
dtfn] = 2kfi[f ] [fn] 2kfi[fn] [fn I krg[ft][fnI
dt
d[f~t]
dt
where [f 't°t] = total protofibrils in fibers;
d[fc']
dtdin = llkpi[f][f10] + kpg[fn][f] -2kfi[fj][cffn]
- kfg[fr] [cfn] where [cfn] = total fibrin in protofibrils;
d[cfr] 2kfi[fn ] [Cf] + kfg[fr] [Cfn]
dt
where [Cfr] = total fibrin in fibers;
average numberefibrin/protofibril: n=
average number protofibril/fiber: m = [fl
average length of fibers: 1 = [Cfr]
[totf
In addition, small oligomers can also associate to form
larger oligomers in a variety of ways. For example, f2 +
fn - gn andf2 +f2 -*f4, et cetera. It is necessary to include
some of these reactions. Without any oligomer-oligo-
mer reactions, oligomers accumulate, slowing protofibril
and fiber growth and producing normal lag periods but a
very slow rise in turbidity. We modeled many permuta-
tions of such oligomer-oligomer reactions, with the re-
sult that there are usually only small differences in the
protofibril/fiber curves with variations ofwhich particu-
lar reactions are included. On the other hand, there can
be great differences in the curves ofsome intermediates.
Some of these differences may be important for under-
standing mechanisms of assembly, but do not seem to
affect the simulated turbidity curves greatly. As more
and more of these reactions are included, the effects be-
come increasingly subtle, if they are noticeable at all.
Thus, it appears to be unnecessary to include all permu-
tations, although this conclusion was not tested because
the computations become prohibitively time con-
suming.
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FIGURE 3 Kinetic modeling of the effects of changes in various rate constants on turbidity curves. The average number of protofibrils per fiber is
plotted as a function oftime. In each set ofcurves, one parameter is varied while all others are held constant; the parameter that is changed is shown
to the right ofthe curves, with the arrows indicating the curves corresponding to an increase in that parameter. The changes in the computed curves
may be compared with the observed turbidity curves of later figures and in other studies. See also Table 1.
These equations and those resulting from a variety of
other possibilities of aggregation of oligomers were
solved. Because the basic results of all of these models
were similar, although details differed, some of these
oligomer reactions were included in all subsequent mod-
eling. In all models featuring a requirement that protofi-
brils reach a minimum length before lateral aggregation,
the curve of protofibrils per fiber versus time shows a
distinct lag period (Fig. 1 c). It should be noted that the
actual kinetic parameters are not known in any detail, so
the shape and general features are more significant than
the actual numerical values. Rate constants have been
chosen to be consistent with known values and to give
curves that resemble those observed.
The average maximum values for number of protofi-
brils per fiber are close to those determined experimen-
tally (Voter, et al., 1986; Weisel and White, unpublished
observations). As discussed above, to obtain this result,
it was found to be necessary that addition of protofibrils
to existing fibers be kinetically favored over initiation of
new fibers by two protofibrils coming together, i.e., kfg
must be larger than kfi. Ifwe assume that protofibril ag-
gregation is cooperative, i.e., big protofibrils grow faster
than small ones, we must add additional reactions such
that rates of adding subsequent protofibrils to a growing
fiber increase. The effect of this modification is to yield
curves where there is a higher maximal rate followed by a
gradual rise rather than a plateau, leading to thicker
fibers.
The length of the lag period in the model varies with
the number ofmonomers added to the protofibril before
it can associate with another protofibril. Experimentally,
TABLE 1 Effects on clot structure and assembly of changes in parameters as determined from kinetic modeling
Results in an increase (t) or decrease (4) in
Increase in Maximum fiber Maximum rate Number
the rate constant size of assembly Lag period of fibers Fiber length
kA- FPA cleavage 4 t 4 t 4
kp/ - pf initiation 4 4 1
kpg - pf growth 0 0 0 0 t
kfi - fiber initiation 4 4 0 4
kfg- fibergrowth t t 4 4 4
kfa - fiber aggregation 0 0 4 4
or fibrinogen conc. t t 4
Abbreviations: FPA = fibrinopeptide A; pf protofibril.
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FIGURE 4 Effects ofthrombin concentration on clot structure and turbidity curves. (a) Turbidity curves for clots formed using different thrombin
concentrations: ( 1 ) 1 unit/ mL; (2) 0.1 unit/ mL; (3) 0.01 unit/mL; (4) 0.001 unit/mL. Compare these curves with the variation ofkA in Fig. 3. (b,
c, and d) Scanning electron micrographs of clots formed using different concentrations of thrombin: (b) 1 unit/mL; (c) 0.01 unit/mL; (d) 0.001
unit/mL. The bar represents 1.0 ,um.
the lag period varies with the conditions of clotting. For
the lag period ofthe model to correspond to that ofclots
formed under approximately physiological conditions, it
was determined that a protofibril must consist of 10-20
monomers. This is very similar to the lengths of protofi-
brils observed (Hantgan, et al., 1980; Medved, et al.,
1990) and the values calculated from light scattering
data (Hantgan and Hermans, 1979).
A model in which the A fibrinopeptides are removed
sequentially was also tested, because this question is still
controversial. Because this modification introduces
many more possible reactions, the complexity increases
greatly. Therefore, the results depend on the assump-
tions made, although for most ofthe rates of fibrinopep-
tide cleavage used for the modeling here, there are no
significant effects on the protofibril/fiber curves. At
slower rates of cleavage, this modification can have ef-
fects on the initial portions of the curves, including the
lag period and rate of fiber growth.
The concentrations of all of the intermediates in clot
formation can also be calculated for any particular ki-
netic parameters. The fibrinogen concentration falls ex-
ponentially, with a rate dependent on kA (Fig. 1 d). Fi-
brin monomer concentration rises rapidly and then falls
at a rate dependent in a complex way on its incorpora-
tion into small oligomers and protofibrils (Fig. 1 e; note
that the rise is more visible with the shorter time scale of
Fig. 2). The concentration of free protofibrils, or those
not incorporated into fibers, rises after a lag period and
then declines as the protofibrils aggregate (Fig. 1 f). The
concentration of protofibrils in fibers increases rapidly
after a lag period and then levels offas protofibril forma-
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FIGURE 5 Effects of salt concentration on clot structure and turbidity curves. (a) Turbidity curves for clots produced in different salt concentra-
tions: ( 1) 0.4 M NaCl; (2) 0.15 M NaCl; (3) 0.05 M NaCl. Compare these curves with the variation of kfg in Fig. 3. (b, c, and d) Scanning electron
micrographs of clots formed in different concentrations of salt: (b) 0.15 M NaCl; (c) 0.4 M NaCl; (d) 0.05 M NaCl. The bar represents 1.0 jAm.
tion ceases when fibrin monomers are used up (Fig. 1 g).
The curve for fiber concentration has a similar shape,
but rises more rapidly and reaches a plateau at a lower
value (Fig. g).
The average length of fibers with time can also be cal-
culated (Fig. 1 h). It is important to note that protofibrils
may grow in length even after they are incorporated into
fibers, a necessary requirement of any realistic model.
Even though the lengths are affected by several of the
rate constants and other aspects ofthe kinetic modeling,
it was discovered that it is difficult to obtain long protofi-
brils or fibers unless kpg is greater than kpi. Although
actual fiber lengths cannot be measured easily, it is appar-
ent from electron micrographs of clots that fibers are
very long. Because we do not know accurately the
lengths of protofibrils and fibers, the difference between
these two rate constants in the examples here is some-
what arbitrarily chosen. However, it does appear that
protofibril elongation must be preferred over the initial
association of monomers to yield a long protofibril.
The various intermediates in clot formation have also
been examined by electron microscopy. Examples of
these structures are shown in Fig. 2, together with the
time courses of the computed concentrations of the in-
termediates. All of the curves have been normalized so
that they can be shown on the same scales for compari-
son of the time courses. Rotary shadowed individual fi-
brinogen molecules are 45-nm long and have a charac-
teristic trinodular shape, with the subdivision of the end
regions apparent in some images (Erickson and Fowler,
1983; Weisel, et al., 1985). Fibrin monomer molecules
were observed by electron microscopy in preparations at
very early stages of clot formation, as suggested by these
curves. Fibrin monomers, obtained by dissolving clots at
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pH 3.5, appear to be generally similar to fibrinogen, sug-
gesting that there are no large-scale conformational
changes upon cleavage ofthe fibrinopeptides. Many pro-
tofibrils were observed from electron microscope prepa-
rations during the lag period, in agreement with these
curves. Negatively contrasted protofibrils are made up of
molecules half-staggered to yield two filaments of mole-
cules bonded end-to-end and twisting around each other
(Fowler, et al., 1981; Medved', et al., 1990). Fibers ap-
pear somewhat later and are best observed before gela-
tion ofthe clot. The fibrin fiber is a paracrystalline struc-
ture with a repeat of 22.5 nm, or half of the molecular
length, as a result of the half-staggered arrangement of
molecules; the band pattern has been related directly to
the molecular structure and packing (Weisel, 1986a).
The curve of protofibrils per fiber, corresponding to tur-
bidity, is related to the clot structure, as illustrated by a
scanning electron micrograph, at lower magnification
than the other micrographs, showing fiber bundles that
aggregate and branch to form a gel.
Kinetic modeling of the effects of
changes in the rates of fibrinopeptide
cleavage, protofibril formation and
lateral aggregation
With the establishment ofthis basic scheme for the steps
of fibrin assembly, the effects of various changes in rate
constants or other factors can be investigated. Some of
these effects are shown in Fig. 3 The average number of
protofibrils per fiber, or turbidity, is plotted versus time.
In each case, one parameter has been varied, keeping all
others constant. The arrows indicate the effects of in-
creasing each parameter. Table 1 also summarizes some
of these conclusions, the effects on average maximum
fiber size, maximum rate of assembly and lag period, in
addition to the effects on other characteristics, such as
the average fiber length and number of fibers. It should
be noted that many of these effects are observed only
within a certain range of values for the rate constants.
Increasing the fibrinogen concentration leads to a de-
crease in the lag period, an increase in the maximum rate
of change and an increase in the maximum final fiber
size (Fig. 3). The number of fibers and their lengths also
increase. Experimental results show similar changes, al-
though it should be noted that, similar to the effects of
salt concentration, opposite effects can occur at higher
fibrinogen concentrations (Ferry and Morrison, 1947).
The effects ofchanges in kA, the rate of fibrinopeptide A
cleavage, are more complex (Fig. 3). Increasing this rate
constant results in a decrease in the lag period, an in-
crease in the maximum rate of fiber growth and a de-
crease in final fiber size. The number of fibers in the final
clot increase, while their average length decreases. The
effects of increasing kj, the rate of initiation of protofi-
bril formation, are generally similar, although the mag-
nitude of some of the changes is considerably different
(Fig. 3). The lag period decreases, the maximum rate of
assembly increases, and the final size decreases, while
both the number offibers and their lengths increase. The
only effect of increasing kp, the rate of protofibril
growth, is to increase the final length of the protofibrils
and hence the fibers, so these changes have not been
included in Fig. 3. Increasing kfi, the rate of initiation of
fiber formation, decreases final fiber size, with little
change in lag period or maximum rate of growth; at the
same time, the number of fibers increase greatly and
fiber length decreases slightly (Fig. 3). As kfg, the rate
constant for addition of protofibrils to fibers, increases
the lag period decreases, the maximum rate of assembly
increases and the final size increases (Fig. 3). Fewer
fibers are formed and they are shorter. Finally, the effects
of aggregation of preformed fibers to yield thicker fiber
bundles (Weisel, 1986b) was also added to the equations
(Fig. 3). There is little effect on the initial portion ofthe
curve, but, rather than leveling off, the fiber size contin-
ues to increase. As a result there are fewer fibers and they
are somewhat shorter.
Experimental observations on
variations in clot structure: turbidity
and electron microscopy
The effects of several different types of changes in envi-
ronmental conditions were measured by monitoring the
changes in turbidity over time and examining the result-
ing clots by scanning electron microscopy. The effects of
changes in thrombin concentration and ionic strength,
as well as the influence of the addition of small amounts
of thrombospondin or platelet factor 4, were deter-
mined. In addition, the effects of some other changes
described in the literature will be evaluated in the Dis-
cussion.
The effects ofthrombin concentration on turbidity de-
velopment are well known. If the thrombin concentra-
tion is high, changes in its concentration have no effect.
With lower amounts ofthrombin, increasing the throm-
bin concentration causes a decrease in the lag period, an
increase in the maximum rate of turbidity development
and a decrease in the maximum final turbidity (Fig. 4
a). Electron micrographs of clots formed with three dif-
ferent thrombin concentrations are also shown in Fig. 4,
b-d. Consistent with the turbidity differences, increasing
thrombin results in more fiber bundles that are thinner.
As thrombin concentration is decreased, the average
fiber bundle size and lag period increases, while the max-
imum rate of turbidity development decreases.
The effects ofionic strength have also been extensively
studied in many laboratories. With an increase in ionic
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strength, the lag period increases, the maximum rate and
the maximum turbidity decrease (Fig. 5 a). Observation
of clots by scanning electron microscopy indicates that,
as ionic strength increases, the number of fiber bundles
increases, but their diameters decrease (Fig. 5, b-d). The
average size of the pores between fiber bundles also de-
creases.
Small amounts of thrombospondin cause striking
changes in the structure of clots (Bale and Mosher,
1986). These changes are especially noticeable at low
concentrations of thrombin. Under these conditions,
thrombospondin causes a decrease in the lag period and
in the final maximum turbidity and an increase in the
number of fibers (Fig. 6, a). Because such conditions are
not represented in the calculated curves of Fig. 3, these
turbidity curves were simulated by calculation of fiber
size at low thrombin concentration with changes in
various rate constants that could be affected by throm-
bospondin. The only changes resembling those observed
arise from an increase in kfi, the rate of initiation of fiber
formation (Fig. 6 b). In addition, the size of the protofi-
brils before lateral aggregation was decreased to simulate
the observed decrease in the lag period; such changes
would be consistent with an increase in kfi, as discussed
below. Scanning electron micrographs corresponding to
the addition of thrombospondin are shown for two dif-
ferent concentrations of thrombin (Fig. 6, c-f).
Very low concentrations of platelet factor 4 cause
changes in turbidity of fibrin clots (Carr, et al., 1987).
There is little change in the beginning portions of the
curves, but final turbidities are significantly larger and
the maximum turbidity continues to rise slowly, rather
than leveling off, as it normally does (Fig. 7, a). These
effects are reflected in the electron micrographs of clots
with increasing amounts of platelet factor 4 (Fig. 7, b-
d), which show thicker fiber bundles with larger pores.
DISCUSSION
Suggestions on the mechanism
of fibrin polymerization from
kinetic modeling
Using information about the chemical reactions in-
volved in fibrin polymerization, equations describing
the kinetics of assembly can be written and then solved
numerically. The results can be related to many experi-
mental observations. Initially, calculated curves of the
number of protofibrils per fiber over time can be com-
pared to measured turbidity profiles. A simple model,
consisting of fibrinopeptide cleavage, protofibril forma-
tion and lateral aggregation to produce fibers, yields
curves indicating that the average fiber size increases rap-
idly and then levels out. The observed lag period can be
simulated by requiring that oligomers reach a certain
minimum length before they can aggregate, a character-
istic of nucleation polymerization rather than condensa-
tion polymerization. Although this conclusion is in
agreement with experimental observations (Hantgan
and Hermans, 1979), the kinetic modeling here suggests
that the requirement ofa minimum protofibril length for
lateral aggregation is not just a result ofthe relative rates
of protofibril growth versus lateral aggregation. Instead,
lateral aggregation may require the cumulative effect of
many weak interactions along protofibrils of sufficient
length. The average size of protofibrils determined from
modeling of the lag period is in good agreement with
electron microscope observations. This reaction scheme
can account for most experimental observations of the
effects of a variety of factors that influence fibrin as-
sembly.
Rate constants for the initial steps of this scheme have
been determined elsewhere and values used in the simu-
lations were similar. Where rate constants were not
known, appropriate values were adjusted to yield curves
of changes in fiber size similar to observed turbidity
curves and electron microscope observations. During
this process, it was found that, to simulate that fiber di-
ameters observed by electron microscopy or calculated
from turbidity or light scattering data, the addition of
protofibrils to existing fibers must be kinetically favored
over the initiation of new fibers by two protofibrils com-
ing together. In other words, addition is faster than initia-
tion. These results suggest that there may be some coop-
erativity in the aggregation of protofibrils.
Similarly, calculation of the lengths of protofibrils and
fibers suggests that the growth of protofibrils may be fa-
vored over initiation of protofibrils; otherwise, the com-
puted average fiber lengths are more limited than might
be expected. This result, however, is tentative for several
reasons, and it is clear that more experimental data are
needed to resolve this question. The lengths offibers can-
not generally be measured from electron micrographs
because it is difficult to discern the ends of fibers and to
trace an individual fiber. Most importantly, such a result
appears to contradict experimental evidence that mono-
mer-monomer association is the same as monomer-oli-
gomer or oligomer-oligomer association (Hantgan and
Hermans, 1979). Finally, this aspect of the simulations
is dependent on the extent to which various types of
oligomer-oligomer associations are significant. Although
this is still unknown, the modeling has demonstrated
that oligomer-oligomer associations are essential to pro-
duce curves similar to the experimental turbidity curves.
The kinetic model described here is based on mecha-
nisms developed from basic evidence and is also consis-
tent with most other experimental studies of assembly.
The initial model has been oversimplified for two rea-
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FIGURE 6 Effects of thrombospondin on clot structure and turbidity curves. (a) Turbidity curves for 0.01 units/mL thrombin and 0.3 mg/mL
fibrinogen, with and without added thrombospondin: C =control, no thrombospondin; tsp = thrombospondin, same conditions as the control with
the addition of 40 AtglmL thrombospondin. (b) Modeling of the turbidity curves in (a); fibrinogen concentration 5 x molecules/L; kA
10's- '(1 ) kfi = 10"2 L/molecule s; kf, = 2 x 10-1 L/molecule s; (2) kfi 020 L/molecule s; kf, 2.4 X 10-1 LL/molecule s (c, d, e, andf)
Scanning electron micrographs of clots with and without thrombospondin: (c) control, 0.3 mg/mL fibrinogen, 0.002 units/mL thrombin; (d) same
conditions with 40 ,Lg/mL thrombospondin; (e) control, 0.3 mg/mL fibrinogen, 0.01 units/mL thrombin; (f) same conditions with 40 jAg/mL
thrombospondin. The bar represents 1.0 jAm.
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FIGURE 7 Effects of platelet factor 4 on clot structure and turbidity curves. (a) Turbidity curves showing the effects ofaddition of platelet factor 4:
( 1) control, no platelet factor 4; (2) same conditions as the control with the addition of 5 ng/mL platelet factor 4; (3) 10 ng/mL platelet factor 4.
Compare these curves with the variation of kfa in Fig. 3 (b, c, and d) Scanning electron micrographs of clots with and without platelet factor 4: (b)
control, no platelet factor 4; (c) same conditions with 5 ng/mL platelet factor 4; (d) 1,000 ng/mL platelet factor 4. The bar represents 1.0 tm.
sons. Even such a simplified model rapidly becomes dif-
ficult to solve mathematically. More importantly, simpli-
fication is necessary to sort out the significance of
various proposed mechanisms. This type of modeling is
important for generating hypotheses than can be tested,
as illustrated in the last paragraph. In whatever ways the
current model fails, it can be modified so that its behav-
ior corresponds more closely to observations. Fibrin as-
sembly is a very complex system whose behavior cannot
always be predicted intuitively. For example, the inter-
play between average fiber diameter and length and num-
ber of fibers directly affects turbidity but can be very
complicated for such a multistep mechanism. Further-
more, this kinetic modeling provides a framework for
thinking about and analyzing the effects ofvarious modi-
fications to the basic scheme.
Conclusions about fibrin assembly
from correlation of kinetic modeling
and structural data
Fibrinopeptide cleavage
The model described here successfully predicts the ef-
fects ofchanges in the rate offibrinopeptide cleavage and
fibrinogen concentration on fiber bundle size (Fig. 3 and
Table 1 ). Experimental curves for thrombin cleavage are
illustrated in Fig. 4; the turbidity curves for different
concentrations of batroxobin, which specifically cleaves
the A fibrinopeptides, were also measured (data not
shown), and, as demonstrated by others (e.g., Shen, et
al., 1977; Carr, et al., 1985; Pirkle, et al., 1986), they are
qualitatively similar to those for thrombin and can be fit
by the kinetic model here. Both experimental and model
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data show that at low enzyme concentrations, or slow
rates ofcleavage, the maximum rate ofgrowth offibers is
slow and the maximum turbidity or fiber size is large.
This result can be described in words as follows: at low
thrombin concentrations, fibrinopeptide cleavage is
slower so that protofibrils are formed more slowly, and
shorter protofibrils aggregate as they are formed, result-
ing in thicker fibers. On the other hand, at higher en-
zyme concentrations, the maximum rate of assembly is
greater and the maximum turbidity is lower. In other
words, here fibrinopeptide cleavage and protofibril for-
mation are rapid compared to lateral aggregation, so
long thin protofibrils are formed before they can aggre-
gate with each other. Aspects ofthe experimental curves
resulting from different enzyme concentrations have
been studied. Plots of maximum turbidity versus maxi-
mum rate of turbidity change are linear (Pirkle, et al.,
1986); plots derived from the calculated curves are simi-
lar. Results from some abnormal fibrinogens where the
rate of cleavage of the A fibrinopeptides is affected may
also be accounted for by this model.
Cleavage of fibrinopeptide B generally follows that of
A temporally and occurs more readily after protofibril
and fiber assembly. The effects of fibrinopeptide B cleav-
age were not directly modeled here, but most of the ef-
fects can be simulated by changes in kfg. Such changes in
lateral aggregation would be expected considering the
measured increase in calcium binding accompanying fi-
brinopeptide B cleavage (Mihalyi, 1988). For example,
cleavage of fibrinopeptide B, like an increase in kfg, can
result in a decrease in the lag period, an increase in the
maximum rate ofturbidity development and an increase
in the maximum turbidity (Shen, et al., 1977; Pirkle, et
al., 1986). Likewise, larger fiber bundles are observed by
electron microscopy upon cleavage of fibrinopeptide B
(Weisel, 1986b; Mosesson, et al., 1987). It should be
noted, however, that the effects offibrinopeptide B cleav-
age can differ from these results because they depend on
the exact experimental conditions (Pirkle, et al., 1986;
Carr, et al., 1985). It should also be mentioned that ex-
perimental results under various conditions where
thrombin is used for clot formation (e.g., results section
above) can be simulated by this model qualitatively even
though only fibrinopeptide A removal is explicitly con-
sidered, because most aspects of fibrinopeptide B cleav-
age can be accounted for simply by variation of kfg, and
hence the curves are similar whether one or both pairs of
peptides are cleaved.
Effects of various factors
on lateral aggregation
A great many studies have linked changes in the chemi-
cal environment of the clot with influences on lateral
aggregation, usually by measurements of turbidity over
time. For example, the effects of salt concentration and
pH are well known (Ferry and Morrison, 1947; Latallo,
et al., 1962; Muller, et al., 1981; Carr, et al., 1985). Cal-
cium ions are one of the most potent modulators of clot
structure. Most of the time, the description of observa-
tions in terms of changes that affect lateral aggregation
has been used somewhat loosely, usually meaning only
that the maximum turbidity or average fiber size was
increased over that under physiological conditions. How-
ever, it is clear from Fig. 3 and Table 1 that there are
several very different mechanisms that would all result
in higher turbidity or fiber size. For example, decreasing
the rates of fibrinopeptide cleavage or fibrin monomer
aggregation or fiber initiation all result in larger fiber
bundles. Here we would like to use lateral aggregation to
mean the addition of protofibrils to a growing fiber. In
investigating the mechanisms and binding sites involved
in lateral aggregation, it is important not to be misled by
the many factors that affect various rates of assembly
and hence turbidity or average sizes of fiber bundles. For
example, the fact that proteolytic removal ofa part ofthe
fibrinogen molecule leads to thinner fibers does not
imply that the portion removed comprises any binding
sites for lateral aggregation.
An increase in the rate of lateral aggregation, or addi-
tion of protofibrils to a fiber, corresponds to an increase
in kfg. From Table 1, it may be observed that kinetic
modeling suggests that an increase in lateral aggregation
commonly results in an increase in the maximal rate of
assembly, a decrease in the lag period, the number of
fibers and the fiber length, as well as an increase in the
maximum average fiber size. Many of these parameters
have been observed in various studies in the past, but
some are more difficult to determine than others. The
average number of fibers formed and their lengths are
very difficult to measure. Of course, the maximum fiber
size, rate of assembly and lag period can be determined
directly from the turbidity curves, with the provisos
mentioned above. On the other hand, not all publica-
tions on this topic show turbidity curves directly; some
include only maximum turbidity, for example. It is possi-
ble, then, to propose that some phenomena described in
the literature result from effects on lateral aggregation in
this strict sense, although in many cases not enough in-
formation is available. In most cases, the maximum tur-
bidity and maximum rate of turbidity development are
increased and the lag period is decreased.
A basic concern is that it is unlikely that many ofthese
environmental factors have effects only on lateral aggre-
gation. For example, changes in salt concentration or pH
will affect the charges ofproteins and hence the intermo-
lecular interactions of all components. Some of these
interactions include the binding of thrombin to fibrino-
gen, the release of cleaved fibrinopeptides, the interac-
tion offibrin monomer to form small oligomers and pro-
tofibrils, all interactions of protofibrils with each other
and with fibers, and fiber/fiber interactions. The overall
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effect will depend on the relative magnitudes of all of
these individual interactions. The effects of proteins and
some other compounds are probably more likely to be
specific in their effects on particular steps ofthe polymer-
ization process.
Thrombospondin affects protofibril association
Several proteins released by activated platelets have ef-
fects on fibrin clot formation. Thrombospondin is a pro-
tein, with a molecular mass of 450 kD made up of three
identical polypeptide chains, that accounts for -25% of
the protein secreted from platelet a granules. This pro-
tein interacts specifically with fibrinogen as well as a few
other clotting proteins and several roles for it in hemosta-
sis and cell adhesion have been proposed (Tuszynski, et
al., 1987). In fibrin formation, small concentrations of
thrombospondin reduce the lag period and the maxi-
mum turbidity. The effects of thrombospondin appear
to be unique in that both the lag period and the maxi-
mum turbidity are decreased. Scanning electron micros-
copy ofclots in the presence ofthrombospondin reveal a
corresponding increase in the number of fiber bundles
but they are thinner. The results presented here are in
general agreement with previous observations, although
in earlier studies the absorbance was measured at a dif-
ferent wavelength and samples were prepared for trans-
mission electron microscopy using a high voltage instru-
ment (Bale and Mosher, 1986).
Bale and Mosher ( 1986) presented a thorough analy-
sis of the interpretation of their results. Even though it
has been demonstrated that thrombin and thrombo-
spondin can form a covalent complex, it seems unlikely
that the observed effects on clot structure arise from any
effect on thrombin or fibrinopeptide cleavage. On the
contrary, thrombospondin also interacts directly with fi-
brin, and it appears that fiber growth is affected by inter-
actions with fibrin intermediates. The three polypeptide
chains ofthrombospondin could comprise three equiva-
lent binding sites for fibrin and may serve as a trifunc-
tional branch point for fibrin intermediates (Bale and
Mosher, 1986).
Some of these suggestions can be analyzed using the
kinetic model described here. Although branching is not
explicitly included in the present kinetic model and so
cannot be tested, the basic concept that thrombospondin
can affect clot structure by specific interactions with fi-
brin oligomers can be. If, as suggested by Bale and
Mosher (1986), thrombospondin can link fibrin oligo-
mers and bring them together, the rate of initiation of
fibers, kfi, and, to a lesser extent, the rate of addition of
protofibrils to fibers, kfg, would be affected. In these ex-
periments there were about nine fibrin molecules for
each thrombospondin, so there would be about one
thrombospondin for each 200 nm of protofibril. In addi-
tion, smaller oligomers might also be brought together so
that the minimum protofibril size that can form aggre-
gates would be decreased, resulting in a decrease in the
lag period.
Because the most striking experimental effects are ob-
served at low thrombin concentration, the effects ofvary-
ing these rate constants on the calculated turbidity pro-
files were determined under the same conditions. In ad-
dition, the minimum protofibril size for lateral
aggregation was decreased, also corresponding to the hy-
pothesis described above. Model curves are in good
agreement with experimental data in that both the lag
period and the average maximum fiber size are de-
creased (Fig. 6). These results are consistent with the
idea that thrombospondin may help to bring protofibrils
together. Thus, shorter oligomers may aggregate, de-
creasing the lag period. Protofibrils would aggregate
more readily, resulting in more thin protofibrils (Table
1 ). These results are similar to what was observed experi-
mentally for thrombospondin. Note that the effects on
fiber size of increasing kfi, the rate of two protofibrils
coming together to initiate a fiber, is opposite to that of
increasing, kfg, the rate of addition of protofibrils to a
growing fiber (i.e., lateral aggregation).
Platelet factor 4 affects fiber aggregation
Platelet factor 4 is a cytokine with a molecular mass of
7.8 kD that is secreted from platelet a granules in a com-
plex with a high molecular weight proteoglycan carrier
(Holt and Niewiarowski, 1989). Platelet factor 4 causes
a striking increase in turbidity and in the average diame-
ter of fiber bundles as observed by electron microscopy
(Fig. 7). The results presented here are similar to those
reported previously (Carr et al., 1987). Even very low
concentrations of platelet factor 4 have profound effects
on turbidity curves. Although it might be expected that
such a phenomenon would be mediated through influ-
ences on the enzymatic cleavage reaction, there does not
appear to be any effect of platelet factor 4 on thrombin
cleavage measured by the thrombin-S2238 assay (Carr,
et al., 1987). The major effect on the turbidity curves is
at later times; the turbidity continues to rise gradually
instead of reaching a plateau quickly (Fig. 7 a; Carr et
al., 1987). By varying the different parameters in the
kinetic model here, it was demonstrated that curves simi-
lar to those observed can be generated by increasing the
rate of aggregation of fibers to form larger fiber bundles,
kfa (see Fig. 3 and Table 1 ). In other words, the increases
in turbidity caused by platelet factor 4 may be accounted
for by aggregation of fibers to yield larger bundles. The
effects of platelet factor 4 are observed even at molar
ratios of fibrin:platelet factor 4 as high as 10,000:1. The
mechanism proposed here could account for this very
low concentration of platelet factor 4 necessary for ob-
servation of these effects, because even a low ratio of
platelet factor 4 to fibrin would represent a large number
of platelet factor 4 molecules per fiber.
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CONCLUSIONS
It has been demonstrated that analysis of the kinetics of
polymerization of fibrin by solution of the differential
equations describing the reactions can be used to help
interpret experimental results from electron microscopy
or turbidity curves. These results reinforce the conclu-
sion from earlier work that clot structure is, to a large
extent, kinetically controlled. In other words, no exter-
nal influences or additional mechanisms are necessary to
account for most experimental observations; it is only
necessary to postulate changes in the various rate con-
stants.
In addition, more complex effects on assembly that
are not intuitively obvious can be quantitatively mod-
eled. For example, in experiments with platelet factor 4,
increasing the rate offiber aggregation is the only change
that causes a slow rise in the final phase ofthe computed
turbidity curves, with few other effects, as observed exper-
imentally. In addition, such a mechanism could account
for the very small amounts of platelet factor 4 that are
effective. The effects of thrombospondin are unique in
that it decreases both the lag period and the maximum
turbidity simultaneously. Here again, the modeling is ex-
tremely helpful because the effects of increasing the rate
of protofibril initiation are not intuitively obvious.
Many other studies in the literature on fibrin assembly in
a variety ofconditions can be interpreted in terms ofthis
scheme of assembly.
It is important to mention several cautionary notes
related to both experimental data in this area and the
modeling. The strengths and weaknesses or limitations
ofthe experimental approaches must be recognized. Tur-
bidity experiments must be very carefully done because
the curves are especially sensitive to any small variations
in conditions and subject to artifacts. In comparing
curves, it is important that the amount of fibrin in the
clot be identical in all experiments. There are two sorts of
possible problems with observations by electron micros-
copy. Clots are relatively fragile structures that are sub-
ject to distortions during preparation for microscopy; an
awareness of the numerous possible problems with dif-
ferent techniques is necessary. Also, by its nature elec-
tron microscopy involves sampling; it is important that
many images from several preparations be examined to
form any conclusions.
Furthermore, aspects of the model may be incorrect,
and it is certainly incomplete. When you examine other
kinetic modeling in the literature, it is apparent that this
model is very complex with a great many adjustable pa-
rameters and the computations may seem almost intrac-
table. On the other hand, with all that we know about
fibrin polymerization, this model may seem to be hope-
lessly oversimplified. Many aspects have been omitted.
For example, fibrinogen binding to fibrin, which is signif-
icant under certain conditions such as low thrombin
concentrations, has not been included. Likewise, any
cooperativity in the removal of fibrinopeptides is not in-
cluded, and fibrinopeptide B cleavage has not been ex-
plicitly considered. There is also no explicit treatment of
branching, although some conclusions may be drawn re-
garding branching, depending on the mechanism. The
turbidity may not be strictly proportional to the size of
the fibers under all conditions, because the number of
fibers in the clot may also have an effect. However, this
would only affect the beginning ofthe curves because the
number of fibers reaches a plateau very quickly (Fig.
1 h).
Initially, we thought that it was better to err in the
direction of oversimplification, to test the basic assump-
tions. Then, additional features can be added later. This
success of this approach is borne out by the results: the
limitations of each model are clear and the effects of
changes are apparent. Also, the "simple" model ac-
counts for a remarkable range of experimental observa-
tions. In addition, many of the rate constants are not
known; it would be extremely useful to have experimen-
tal values for all of these parameters. However, this
model can easily be modified to take any of these
changes into account. On the other hand, kinetic studies
do not provide direct information on mechanisms of as-
sembly. For understanding mechanisms, biochemical
and structural studies are necessary to define the binding
sites involved and characterize other aspects of as-
sembly.
The major strengths of kinetic modeling lie in identi-
fying the consequences of a particular proposed mecha-
nism or changes in some aspect of assembly on mea-
sured properties such as turbidity profiles or clot struc-
ture as observed by electron microscopy. Whenever
more structural and biochemical data are available, sug-
gesting further hypotheses regarding mechanisms of as-
sembly, the consequences can be critically examined by
modeling similar to that described here.
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